JUNE 2023 / OUR CSO AND CO-FOUNDER VICTOR GUALLER SPEAKING AT THE NEXT-GENERATION DEGRADERS & GLUES CONFERENCE, LONDON, 20-22 JUNE
Finding hits, even for molecular glues, might no be a problem anymore with modern virtual screening. The main problem now shifts to generating the right target, and we might have the best in silico modeling solution for ligase screening and target generation.
APRIL 2023 / NOSTRUM BIODISCOVERY TAKES PART IN THE AMBITIOUS MDDB EUROPEAN PROJECT TO CREATE THE FIRST DATABASE OF MOLECULAR DYNAMICS.
Nostrum Biodiscovery is one of the key partners in the ambitious european MDDB project, which was officially launched last 24-25th of april in Barcelona. Researchers led by Dr. Modesto Orozco, co-funder and president of Nostrum Biodiscovery, and head of the Molecular Modelling and Bioinformatics lab at IRB Barcelona, aim to develop the first European database of molecular dynamics. In the upcoming three years, the scientists will establish the groundwork for an infrastructure that enhances the use of computational resources, enables data analysis from multiple perspectives, ensures rapid and efficient information exchange among various institutions, and promotes the incorporation of molecular dynamics into other research domains.
APRIL 2023 / ENAMINE & NOSTRUM BIODISCOVERY COLLABORATION
We are excited to announce a game-changing partnership between Nostrum Biodiscovery, a frontrunner in computational drug discovery services, and ENAMINE, a worldwide supplier of chemical building blocks and screening compounds. These two powerhouses are joining forces to co-develop a cutting-edge search engine specifically for the REAL Space billion database, delivering unprecedented performance in searching vast chemical spaces with minimal computational resources.